Clinical trials
Terminated Coronary Artery Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
265 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 5 |
| 2004 | 5 |
| 2005 | 8 |
| 2006 | 14 |
| 2007 | 18 |
| 2008 | 17 |
| 2009 | 21 |
| 2010 | 20 |
| 2011 | 20 |
| 2012 | 18 |
| 2013 | 10 |
| 2014 | 12 |
| 2015 | 18 |
| 2016 | 14 |
| 2017 | 10 |
| 2018 | 14 |
| 2019 | 12 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 265 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seung-Jung Park | 11 |
| Abbott Medical Devices | 6 |
| Ottawa Heart Institute Research Corporation | 6 |
| Yonsei University | 5 |
| Cordis US Corp. | 4 |
| GE Healthcare | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| CHEOL WHAN LEE, M.D., Ph.D | 3 |
| Corewell Health East | 3 |
| Duk-Woo Park, MD | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 265 |
| Myocardial Infarction | 21 |
| Acute Coronary Syndrome | 19 |
| Myocardial Ischemia | 18 |
| Cardiovascular Diseases | 16 |
| Heart Diseases | 16 |
| Atherosclerosis | 15 |
| Chest Pain | 12 |
| Coronary Disease | 12 |
| Angina Pectoris | 11 |
Trials
Showing 1 to 25 of 265. Each trial links to its page on Pharma Observatory.
165 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.